k awasaki disease (KD), also known as mucocutaneous lymph node syndrome, is predominantly a disease occurring in childhood which consists of medium-vessel vasculitis (1, 2) . The most important concern is coronary artery aneurysm formation, which may be fatal if left untreated. However, there were only few reports on renal injury in patients with KD.
With nuclear imaging technology, renal involvement was reported in 52% of the KD patients, but acute kidney injury (AKI) defined by serum creatinine elevation was very uncommon (3) . Only few cases of KD patients with AKI underwent renal biopsy, and pathology revealed tubulointerstitial nephritis (4-6) or hemolytic uremic syndrome (7) . However, pediatric patients with renal injury may be underestimated due to absence of clear definition and lack of age-specific normal values of serum creatinine. This is especially true among patients with KD, since the peak incidence falls below 2 y old. In response to the advent of recently developed age-specific reference for serum creatinine level in pediatric population (8) , this study aims to identify the rate and factors associated with renal injury in KD patients.
RESULTS
From February 2004 to August 2014, a total of 356 patients were enrolled consecutively in this study. Among them, 13 patients did not receive checks on serum creatinine level upon admission, 2 patients lacked cardiac echo exam reports, 6 patients had coincident urinary tract infection, one patient had congenital small kidneys, and 2 patients suffered from Kawasaki disease shock syndrome. They were excluded from subsequent analyses.
The remaining 332 patients (191 boys and 141 girls; aged 0.12 to 11.3 y, median 1.39 y) were further analyzed ( Table 1) . Infants below 6 mo old represented 16.0% of the cases, whereas the majority (52.4%) of the patients were between 6 mo old to 2 y old. Ninety-three patients (28.0%) had AKI among which 7 patients (2.1%) had more severe renal injury, with serum creatinine level higher than two times of normal upper limit. The age distribution of KD patients with or without AKI was shown in Figure 1 . For patients under 1 y old, the incidence of AKI was 47.1%, which was much higher than those over 1 y old (17.4 %; P < 0.01).
Among the 331 patients who received checks on C-reactive protein, the level was elevated (median 6.00, 0.01-26.50 mg/ dl) and 80.7% of the patients levelled above 3 mg/dl. Among the 266 patients who received checks on alanine transaminase, the median level was 37 (3-909) U/l, with 48.1% of the patients levelling above 40 U/l. Among the 279 patients with urinalysis data, 31.5% had sterile pyuria, which was defined as urine white blood cell count equal or more than 10/HPF. Among 59 patients who received renal ultrasound, 57.6% had nephromegaly.
All patients received treatments with intravenous immunoglobulin and antiplatelet medication. By performing serial echocardiography, 21.7% had coronary artery abnormalities, including 6.3% coronary artery aneurysm and 15.4% coronary ectasia. For patients with coronary artery aneurysm, antiplatelet medications were kept for longer periods as needed.
In univariate analysis, age (median 0.88, range 0.12-4.67) in AKI group was significantly (P < 0.01) lower than that (median Acute kidney injury in Kawasaki patients Articles 1.63, range 0.12-11.25) in non-AKI group ( Table 2) ; alanine transaminase level was significantly higher in AKI group than in non-AKI group (P < 0.01); pyuria was more prevalent in AKI group than in non-AKI group (P < 0.01). Other clinical or laboratory parameters did not show significant difference between the two groups.
We then performed multivariate logistic regression for factors associated with AKI revealed in univariate analysis (Table 3) , and found only age and alanine transaminase level were significantly associated with AKI (odds ratio (OR): 0.521, 95% confidence interval (CI): 0.377-0.718, P < 0.001, and OR: 1.003, 95% CI: 1.000-1.005, P = 0.017, respectively).
DISCUSSION
Renal involvement in patients with KD had been reported before (3-7); however, no study had been designed with the specific aim to explore the incidence of AKI. The present study documents that a high incidence of AKI (28.0%) was present in patients with KD. As KD is a disease of medium-vessel vasculitis, renal or intrarenal arterial inflammation might be the major cause of AKI. Earlier review summarized and indicated that vasculitis of arteries in the kidney, immune-complexmediated renal injuries, and T-cell immune-regulatory abnormalities might be underlying mechanisms, although the precise mechanism of kidney involvement and renal injury in KD patients remains unclear (9) .
There has always been difficulty in assessing renal function in pediatric population. Except in neonatal period, serum creatinine level increases gradually with age. References in the era of conventional Jaffe method should not be used nowadays, as serum creatinine level would have great difference (falsely higher in conventional Jaffe method than compensated Jaffe method for more than 0.3 mg/dl) (10). Moreover, many serum creatinine references were inappropriate for our study group due to lack of narrow age range grouping (e.g., broader grouping such as 0-4, 4-7, and 7-10 y old). Since the peak incidence of patients with KD falls below 2 y old, therefore, we employed the results reported recently by Soeby et al. (8) to define AKI in this younger age population.
Chang et al. (11) revealed that patients with KD younger than 6 mo of age were more likely to have atypical presentation, and in this age group, incidence of coronary artery abnormalities was significantly higher, thus earlier recognition of KD among febrile infants is crucial. Our study demonstrated that age is significantly associated (P < 0.001; OR: 0.521; 95% CI: 0.377-0.718) with AKI, which indicates a higher incidence of AKI in younger patients. Among infants with KD, the incidence of AKI is 47.1%. Therefore, we suggest measurement of serum creatinine level in infants and children with KD for early detection and appropriate management of AKI.
Huang et al. (12) reported a high incidence (70% of 20 cases) of nephromegaly in patients with KD who had ever received renal ultrasound exam. A higher plasma hepatocyte growth factor (HGF) to transforming growth factor β1 (TGF-β1) ratio (HGF/TGF-β1) was noted in patients with KD. Previously, a higher HGF/TGF-β1 ratio in patients with biliary atresia was demonstrated to be associated with increased kidney volume and a higher glomerular filtration rate (13) . Should the higher Articles Chuang et al.
HGF/TGF-β1 ratio be observed in the patients with KD, nephromegaly should represent a proliferative status with a higher glomerular filtration rate and thus lower chance of AKI. However, in our current study, the incidence of nephromegaly was slightly higher in AKI group than in non-AKI group (63.6 vs. 54.6%, P > 0.05). Thus, the association between nephromegaly and renal function in patients with KD is not clear and remains to be further explored. Hepatic dysfunction had been documented in patients with KD (14) . Eladawy et al. (15) reported 37.2% of abnormal alanine transaminase or aspartate transaminase among patients with KD. Our study showed 48.1% of patients with KD had elevated alanine transaminase level. When comparing AKI group with non-AKI group, a slightly higher level was noted in the former group, supporting the fact that KD is a multi-organ disease, and inflammation severity of liver and kidney might be closely related.
There are some limitations of our study. First, it is a retrospective study and the baseline serum creatinine level was not checked. Therefore, we might underestimate the incidence of AKI as some patients with AKI might not be identified due to lack of the baseline level. Second, no biopsy was done to demonstrate the underlying mechanism of renal injury. Third, fractional excretion of sodium, urinary β2-microglobulin, or gallium or 99mTc-DMSA renal scintigraphy were not examined in this study to identify causes of AKI. However, from our present study, we strongly recommend patients with KD to check serum creatinine and alanine transaminase levels routinely during both acute phase and convalescent phase to evaluate if renal and hepatic injury is present.
In conclusion, this is the first study to use age-specific serum creatinine reference to evaluate renal function in pediatric patients with KD. Contrary to previous understanding, substantial proportion of patients with KD actually has AKI, suggesting a multi-organ involvement of this disease. The associated factors of patients with KD developing AKI are young age and hepatic dysfunction.
METHODS

Study Population
We retrospectively reviewed children admitted to a medical center in Taipei, the National Taiwan University Hospital, who were diagnosed with acute febrile KD from February 2004 to August 2014. The exclusion criteria were: (i) lack of serum creatinine data or echocardiography reports, (ii) coincident urinary tract infection or congenital renal anomalies, or (iii) having other conditions that can directly cause acute kidney injury such as shock. The study protocol was approved by the institutional review board of National Taiwan University Hospital (201511063RIND). As a retrospective study, subject and/or parental informed consent was not obtained.
KD was defined according to AHA 2004 diagnostic criteria (16) . Diagnosis of complete KD was based on the presence of 5 d of fever and four of the following five principal clinical features: (i) changes in extremities, (ii) polymorphous exanthema, (iii) bilateral bulbar conjunctival injection without exudates, (iv) changes in lips and oral cavity, and (v) cervical lymphadenopathy (diameter >1.5 cm). Patients with fever for 5 d but having less than four principal features were then diagnosed as having atypical KD if coronary artery disease was detected by either 2D echocardiography or coronary angiography. Data collected include serum creatinine level, serial echocardiography reports, white blood cell count, C-reactive protein level, alanine transaminase level, urine white blood cell count, and renal ultrasound reports if available. The serum creatinine level was measured using a chemistry analyzer (Toshiba 200FR, Toshiba Medical Systems, Tokyo, Japan during 2004-2010; AU5800, Beckman Coulter, Brea, California since 2011) with compensated Jaffe method.
According to 2011 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for Acute Kidney Injury (17), AKI is defined Mann-Whitney U-test. ALT, alanine transaminase; AKI, acute kidney injury; CRP, C-reactive protein; dl, deciliter; hPF, high-power field; μl micro-liter; WBC, white blood cell. 
